info@alphabioresearch.com
(+34) 91 745 25 20
With more than 25 years of experience we represent a solid alternative to the big players in the sector
Clinical Investigation
We are a full service contract research organization (CRO), offering a broad experience in the development of clinical studies in all phases (I – IV and post-authorization). This has allowed us to be able to adapt to different legislations and applicable technologies in the world of clinical research.
We provide our experience in clinical investigation, maintaining the highest quality standards at all times and within agreed timelines. Your goal is our ambition.
Global activity
At Alpha Bioresearch we provide an operational structure that allows us to perform all activities, from the development of the protocol and the necessary
methodology to start the study, to data management and analysis with the final study report.
The specialization and professionality of our employees ensure that our clients can take full advantage of our services, thereby achieving cost reduction
and optimization of their investments.
Types of studies
In the last 5 years Alpha Bioresearch has performed 134 studies evaluating more than 32.6000 patients distributed in 3.000 sites, both public and private.
59%
Clinical Trials
41%
Observational Studies
Types of products
Therapeutic
areas
Alpha Bioresearch offers vast experience in various therapeutic areas with drugs, medical devices and dietary supplements (see graph).
At Alpha Bioresearch we have managed more than 3.000 public and private primary care centers and hospitals across Europe, guaranteeing the highest quality standards in the services it provides.
Specialization
Advanced therapies
Differentiation
Gene therapy vs Cell therapy
Therapeutic areas
in which they apply
Oncology
The prevention and personalization of treatments are necessary. Therefore, clinical research is essential to improve the patient´s quality of life. In the last five years, Alpha Bioresearch has taken part in 30 oncological studies, taking more than 6.090 patients distributed in 564 centers.
Clients
These are some of the institutions and companies, both public and private, that have benefited from our services.
